Limited Role of MSAFP Screening for Prenatal Omphalocele Detection
Journal of Ultrasound in Medicine · 2024
DOI: 10.1002/jum.16562 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Ultrasound in Medicine, 2024. Verfasst von Christian M Parobek und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas, USA. Hauptthemen laut MEDLINE: Hernia, Umbilical, Ultrasonography, Prenatal, alpha-Fetoproteins. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences.
Abstract (Originalsprache)
Objectives
Although serum screening for aneuploidies has become less prevalent, maternal‐serum alpha‐fetoprotein (MSAFP) screening for body‐wall defects remains widespread. We explored whether MSAFP screening is associated with earlier omphalocele detection than ultrasound alone.
Methods
This is a retrospective cohort study of prenatally detected omphalocele cases at our center from 2007 to 2023. We explored the association between MSAFP screening, gestational age at omphalocele detection, and clinical outcomes.
Results
Among 101 pregnancies with prenatally diagnosed omphalocele, 27 (26.7%) had MSAFP screening. The median gestational age at MSAFP screening was 17 weeks 4 days. Of those who received MSAFP screening, 11 (41%) had values ≥2.5 multiples of the median (MoM) and 16 (59%) were not elevated. MSAFP results did not correlate with omphalocele size and were not associated with prenatal or postnatal outcomes. MSAFP screening did not result in earlier suspicion for or confirmation of omphalocele ( P = .97 and P = .87, respectively). In contrast, first‐trimester ultrasound screening was associated with earlier suspicion for and confirmation of omphalocele ( P < .01 and P = .01, respectively). There were no clinical or demographic differences between those who received MSAFP screening and those who did not (including body mass index or commute distance to an urban center).
Conclusion
MSAFP screening is not associated with earlier omphalocele detection. Furthermore, in pregnancies with prenatally diagnosed omphalocele, the results of MSAFP screening are not predictive of clinical outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas, USA.
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
- Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas, USA.
ORCID-Profile: Christian M Parobek
Förderung
- NIGMS NIH HHS
- National Institute of General Medical Sciences
Zitieren
APA
Parobek, C. M., Shanahan, M. A., Burnett, B. A., Dadoun, S. E., & Adams, A. D. (2024). Limited Role of MSAFP Screening for Prenatal Omphalocele Detection. Journal of Ultrasound in Medicine. https://doi.org/10.1002/jum.16562
Vancouver
Parobek CM, Shanahan MA, Burnett BA, Dadoun SE, Adams AD. Limited Role of MSAFP Screening for Prenatal Omphalocele Detection. Journal of Ultrasound in Medicine. 2024. doi:10.1002/jum.16562
BibTeX
@article{Parobek2024,
author = {Parobek, Christian M and Shanahan, Matthew A and Burnett, Brian A and Dadoun, Simon E and Adams, April D},
title = {Limited Role of MSAFP Screening for Prenatal Omphalocele Detection},
journal = {Journal of Ultrasound in Medicine},
year = {2024},
doi = {10.1002/jum.16562}
}
EUVIMED